Covid-19 Impact on Global Biosimilar Monoclonal Antibodies Market Size, Status and Forecast 2020-2026
Table of Contents1 Study Coverage
1.1 Biosimilar Monoclonal Antibodies Product Introduction
1.2 Market Segments
1.3 Key Biosimilar Monoclonal Antibodies Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type
1.4.2 Infliximab
1.4.3 Rituximab
1.4.4 Trastuzumab
1.4.5 Adalimumab
1.4.6 Other
1.5 Market by Application
1.5.1 Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application
1.5.2 Oncology
1.5.3 Autoimmune Disease
1.5.4 Other
1.6 Coronavirus Disease 2019 (Covid-19): Biosimilar Monoclonal Antibodies Industry Impact
1.6.1 How the Covid-19 is Affecting the Biosimilar Monoclonal Antibodies Industry
1.6.1.1 Biosimilar Monoclonal Antibodies Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19's Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Biosimilar Monoclonal Antibodies Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Biosimilar Monoclonal Antibodies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Global Biosimilar Monoclonal Antibodies Market Size Estimates and Forecasts
2.1.1 Global Biosimilar Monoclonal Antibodies Revenue 2015-2026
2.1.2 Global Biosimilar Monoclonal Antibodies Sales 2015-2026
2.2 Biosimilar Monoclonal Antibodies Market Size by Region: 2020 Versus 2026
2.2.1 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Biosimilar Monoclonal Antibodies Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Biosimilar Monoclonal Antibodies Competitor Landscape by Players
3.1 Biosimilar Monoclonal Antibodies Sales by Manufacturers
3.1.1 Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015-2020)
3.1.2 Biosimilar Monoclonal Antibodies Sales Market Share by Manufacturers (2015-2020)
3.2 Biosimilar Monoclonal Antibodies Revenue by Manufacturers
3.2.1 Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2015-2020)
3.2.2 Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Biosimilar Monoclonal Antibodies Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Biosimilar Monoclonal Antibodies Revenue in 2019
3.2.5 Global Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Biosimilar Monoclonal Antibodies Price by Manufacturers
3.4 Biosimilar Monoclonal Antibodies Manufacturing Base Distribution, Product Types
3.4.1 Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Biosimilar Monoclonal Antibodies Product Type
3.4.3 Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Biosimilar Monoclonal Antibodies Market Size by Type (2015-2020)
4.1.1 Global Biosimilar Monoclonal Antibodies Sales by Type (2015-2020)
4.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020)
4.1.3 Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Biosimilar Monoclonal Antibodies Market Size Forecast by Type (2021-2026)
4.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Type (2021-2026)
4.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Type (2021-2026)
4.2.3 Biosimilar Monoclonal Antibodies Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Biosimilar Monoclonal Antibodies Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Breakdown Data by Application (2015-2026)
5.1 Global Biosimilar Monoclonal Antibodies Market Size by Application (2015-2020)
5.1.1 Global Biosimilar Monoclonal Antibodies Sales by Application (2015-2020)
5.1.2 Global Biosimilar Monoclonal Antibodies Revenue by Application (2015-2020)
5.1.3 Biosimilar Monoclonal Antibodies Price by Application (2015-2020)
5.2 Biosimilar Monoclonal Antibodies Market Size Forecast by Application (2021-2026)
5.2.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Application (2021-2026)
5.2.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Application (2021-2026)
5.2.3 Global Biosimilar Monoclonal Antibodies Price Forecast by Application (2021-2026)
6 North America
6.1 North America Biosimilar Monoclonal Antibodies by Country
6.1.1 North America Biosimilar Monoclonal Antibodies Sales by Country
6.1.2 North America Biosimilar Monoclonal Antibodies Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Biosimilar Monoclonal Antibodies Market Facts & Figures by Type
6.3 North America Biosimilar Monoclonal Antibodies Market Facts & Figures by Application
7 Europe
7.1 Europe Biosimilar Monoclonal Antibodies by Country
7.1.1 Europe Biosimilar Monoclonal Antibodies Sales by Country
7.1.2 Europe Biosimilar Monoclonal Antibodies Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures by Type
7.3 Europe Biosimilar Monoclonal Antibodies Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Biosimilar Monoclonal Antibodies by Region
8.1.1 Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region
8.1.2 Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Biosimilar Monoclonal Antibodies Market Facts & Figures by Type
8.3 Asia Pacific Biosimilar Monoclonal Antibodies Market Facts & Figures by Application
9 Latin America
9.1 Latin America Biosimilar Monoclonal Antibodies by Country
9.1.1 Latin America Biosimilar Monoclonal Antibodies Sales by Country
9.1.2 Latin America Biosimilar Monoclonal Antibodies Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Biosimilar Monoclonal Antibodies Market Facts & Figures by Type
9.3 Central & South America Biosimilar Monoclonal Antibodies Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Biosimilar Monoclonal Antibodies by Country
10.1.1 Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country
10.1.2 Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Biosimilar Monoclonal Antibodies Market Facts & Figures by Type
10.3 Middle East and Africa Biosimilar Monoclonal Antibodies Market Facts & Figures by Application
11 Company Profiles
11.1 Celltrion
11.1.1 Celltrion Corporation Information
11.1.2 Celltrion Description, Business Overview and Total Revenue
11.1.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered
11.1.5 Celltrion Recent Development
11.2 Pfizer (Hospira)
11.2.1 Pfizer (Hospira) Corporation Information
11.2.2 Pfizer (Hospira) Description, Business Overview and Total Revenue
11.2.3 Pfizer (Hospira) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer (Hospira) Biosimilar Monoclonal Antibodies Products Offered
11.2.5 Pfizer (Hospira) Recent Development
11.3 3SBIO
11.3.1 3SBIO Corporation Information
11.3.2 3SBIO Description, Business Overview and Total Revenue
11.3.3 3SBIO Sales, Revenue and Gross Margin (2015-2020)
11.3.4 3SBIO Biosimilar Monoclonal Antibodies Products Offered
11.3.5 3SBIO Recent Development
11.4 Novartis (Sandoz)
11.4.1 Novartis (Sandoz) Corporation Information
11.4.2 Novartis (Sandoz) Description, Business Overview and Total Revenue
11.4.3 Novartis (Sandoz) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Novartis (Sandoz) Biosimilar Monoclonal Antibodies Products Offered
11.4.5 Novartis (Sandoz) Recent Development
11.5 Dr Reddy's
11.5.1 Dr Reddy's Corporation Information
11.5.2 Dr Reddy's Description, Business Overview and Total Revenue
11.5.3 Dr Reddy's Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Dr Reddy's Biosimilar Monoclonal Antibodies Products Offered
11.5.5 Dr Reddy's Recent Development
11.6 Celgen Biopharma
11.6.1 Celgen Biopharma Corporation Information
11.6.2 Celgen Biopharma Description, Business Overview and Total Revenue
11.6.3 Celgen Biopharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Celgen Biopharma Biosimilar Monoclonal Antibodies Products Offered
11.6.5 Celgen Biopharma Recent Development
11.7 Cadila Healthcare
11.7.1 Cadila Healthcare Corporation Information
11.7.2 Cadila Healthcare Description, Business Overview and Total Revenue
11.7.3 Cadila Healthcare Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Cadila Healthcare Biosimilar Monoclonal Antibodies Products Offered
11.7.5 Cadila Healthcare Recent Development
11.8 Hisun Pharma
11.8.1 Hisun Pharma Corporation Information
11.8.2 Hisun Pharma Description, Business Overview and Total Revenue
11.8.3 Hisun Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Hisun Pharma Biosimilar Monoclonal Antibodies Products Offered
11.8.5 Hisun Pharma Recent Development
11.9 Torrent Pharmaceuticals
11.9.1 Torrent Pharmaceuticals Corporation Information
11.9.2 Torrent Pharmaceuticals Description, Business Overview and Total Revenue
11.9.3 Torrent Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Products Offered
11.9.5 Torrent Pharmaceuticals Recent Development
11.1 Celltrion
11.1.1 Celltrion Corporation Information
11.1.2 Celltrion Description, Business Overview and Total Revenue
11.1.3 Celltrion Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Celltrion Biosimilar Monoclonal Antibodies Products Offered
11.1.5 Celltrion Recent Development
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Biosimilar Monoclonal Antibodies Market Estimates and Projections by Region
12.1.1 Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions 2021-2026
12.1.2 Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions 2021-2026
12.2 North America Biosimilar Monoclonal Antibodies Market Size Forecast (2021-2026)
12.2.1 North America: Biosimilar Monoclonal Antibodies Sales Forecast (2021-2026)
12.2.2 North America: Biosimilar Monoclonal Antibodies Revenue Forecast (2021-2026)
12.2.3 North America: Biosimilar Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
12.3 Europe Biosimilar Monoclonal Antibodies Market Size Forecast (2021-2026)
12.3.1 Europe: Biosimilar Monoclonal Antibodies Sales Forecast (2021-2026)
12.3.2 Europe: Biosimilar Monoclonal Antibodies Revenue Forecast (2021-2026)
12.3.3 Europe: Biosimilar Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Biosimilar Monoclonal Antibodies Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Biosimilar Monoclonal Antibodies Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Biosimilar Monoclonal Antibodies Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Biosimilar Monoclonal Antibodies Market Size Forecast by Region (2021-2026)
12.5 Latin America Biosimilar Monoclonal Antibodies Market Size Forecast (2021-2026)
12.5.1 Latin America: Biosimilar Monoclonal Antibodies Sales Forecast (2021-2026)
12.5.2 Latin America: Biosimilar Monoclonal Antibodies Revenue Forecast (2021-2026)
12.5.3 Latin America: Biosimilar Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Biosimilar Monoclonal Antibodies Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Biosimilar Monoclonal Antibodies Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Biosimilar Monoclonal Antibodies Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Biosimilar Monoclonal Antibodies Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Biosimilar Monoclonal Antibodies Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Biosimilar Monoclonal Antibodies Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
List of TablesTable 1. Biosimilar Monoclonal Antibodies Market Segments
Table 2. Ranking of Global Top Biosimilar Monoclonal Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Infliximab
Table 5. Major Manufacturers of Rituximab
Table 6. Major Manufacturers of Trastuzumab
Table 7. Major Manufacturers of Adalimumab
Table 8. Major Manufacturers of Other
Table 9. COVID-19 Impact Global Market: (Four Biosimilar Monoclonal Antibodies Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Biosimilar Monoclonal Antibodies Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Biosimilar Monoclonal Antibodies Players to Combat Covid-19 Impact
Table 14. Global Biosimilar Monoclonal Antibodies Market Size Growth Rate by Application 2020-2026 (K Units)
Table 15. Global Biosimilar Monoclonal Antibodies Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 16. Global Biosimilar Monoclonal Antibodies Sales by Regions 2015-2020 (K Units)
Table 17. Global Biosimilar Monoclonal Antibodies Sales Market Share by Regions (2015-2020)
Table 18. Global Biosimilar Monoclonal Antibodies Revenue by Regions 2015-2020 (US$ Million)
Table 19. Global Biosimilar Monoclonal Antibodies Sales by Manufacturers (2015-2020) (K Units)
Table 20. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturers (2015-2020)
Table 21. Global Biosimilar Monoclonal Antibodies Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 22. Global Biosimilar Monoclonal Antibodies by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilar Monoclonal Antibodies as of 2019)
Table 23. Biosimilar Monoclonal Antibodies Revenue by Manufacturers (2015-2020) (US$ Million)
Table 24. Biosimilar Monoclonal Antibodies Revenue Share by Manufacturers (2015-2020)
Table 25. Key Manufacturers Biosimilar Monoclonal Antibodies Price (2015-2020) (USD/Unit)
Table 26. Biosimilar Monoclonal Antibodies Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Biosimilar Monoclonal Antibodies Product Type
Table 28. Date of International Manufacturers Enter into Biosimilar Monoclonal Antibodies Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 31. Global Biosimilar Monoclonal Antibodies Sales Share by Type (2015-2020)
Table 32. Global Biosimilar Monoclonal Antibodies Revenue by Type (2015-2020) (US$ Million)
Table 33. Global Biosimilar Monoclonal Antibodies Revenue Share by Type (2015-2020)
Table 34. Biosimilar Monoclonal Antibodies Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 35. Global Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 36. Global Biosimilar Monoclonal Antibodies Sales Share by Application (2015-2020)
Table 37. North America Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units)
Table 38. North America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 39. North America Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 40. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 41. North America Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 42. North America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 43. North America Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 44. North America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 45. Europe Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units)
Table 46. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 47. Europe Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 48. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 49. Europe Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 50. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 51. Europe Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 52. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 53. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Region (2015-2020) (K Units)
Table 54. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Table 55. Asia Pacific Biosimilar Monoclonal Antibodies Revenue by Region (2015-2020) (US$ Million)
Table 56. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Table 57. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 58. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 59. Asia Pacific Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 60. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 61. Latin America Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units)
Table 62. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 63. Latin Americaa Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 64. Latin America Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 65. Latin America Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 66. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 67. Latin America Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 68. Latin America Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 69. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Country (2015-2020) (K Units)
Table 70. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Country (2015-2020)
Table 71. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue by Country (2015-2020) (US$ Million)
Table 72. Middle East and Africa Biosimilar Monoclonal Antibodies Revenue Market Share by Country (2015-2020)
Table 73. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Type (2015-2020) (K Units)
Table 74. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Table 75. Middle East and Africa Biosimilar Monoclonal Antibodies Sales by Application (2015-2020) (K Units)
Table 76. Middle East and Africa Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Table 77. Celltrion Corporation Information
Table 78. Celltrion Description and Major Businesses
Table 79. Celltrion Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 80. Celltrion Product
Table 81. Celltrion Recent Development
Table 82. Pfizer (Hospira) Corporation Information
Table 83. Pfizer (Hospira) Description and Major Businesses
Table 84. Pfizer (Hospira) Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 85. Pfizer (Hospira) Product
Table 86. Pfizer (Hospira) Recent Development
Table 87. 3SBIO Corporation Information
Table 88. 3SBIO Description and Major Businesses
Table 89. 3SBIO Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. 3SBIO Product
Table 91. 3SBIO Recent Development
Table 92. Novartis (Sandoz) Corporation Information
Table 93. Novartis (Sandoz) Description and Major Businesses
Table 94. Novartis (Sandoz) Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 95. Novartis (Sandoz) Product
Table 96. Novartis (Sandoz) Recent Development
Table 97. Dr Reddy's Corporation Information
Table 98. Dr Reddy's Description and Major Businesses
Table 99. Dr Reddy's Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Dr Reddy's Product
Table 101. Dr Reddy's Recent Development
Table 102. Celgen Biopharma Corporation Information
Table 103. Celgen Biopharma Description and Major Businesses
Table 104. Celgen Biopharma Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 105. Celgen Biopharma Product
Table 106. Celgen Biopharma Recent Development
Table 107. Cadila Healthcare Corporation Information
Table 108. Cadila Healthcare Description and Major Businesses
Table 109. Cadila Healthcare Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 110. Cadila Healthcare Product
Table 111. Cadila Healthcare Recent Development
Table 112. Hisun Pharma Corporation Information
Table 113. Hisun Pharma Description and Major Businesses
Table 114. Hisun Pharma Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 115. Hisun Pharma Product
Table 116. Hisun Pharma Recent Development
Table 117. Torrent Pharmaceuticals Corporation Information
Table 118. Torrent Pharmaceuticals Description and Major Businesses
Table 119. Torrent Pharmaceuticals Biosimilar Monoclonal Antibodies Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 120. Torrent Pharmaceuticals Product
Table 121. Torrent Pharmaceuticals Recent Development
Table 122. Global Biosimilar Monoclonal Antibodies Sales Forecast by Regions (2021-2026) (K Units)
Table 123. Global Biosimilar Monoclonal Antibodies Sales Market Share Forecast by Regions (2021-2026)
Table 124. Global Biosimilar Monoclonal Antibodies Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 125. Global Biosimilar Monoclonal Antibodies Revenue Market Share Forecast by Regions (2021-2026)
Table 126. North America: Biosimilar Monoclonal Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 127. North America: Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 128. Europe: Biosimilar Monoclonal Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 129. Europe: Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 130. Asia Pacific: Biosimilar Monoclonal Antibodies Sales Forecast by Region (2021-2026) (K Units)
Table 131. Asia Pacific: Biosimilar Monoclonal Antibodies Revenue Forecast by Region (2021-2026) (US$ Million)
Table 132. Latin America: Biosimilar Monoclonal Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 133. Latin America: Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Middle East and Africa: Biosimilar Monoclonal Antibodies Sales Forecast by Country (2021-2026) (K Units)
Table 135. Middle East and Africa: Biosimilar Monoclonal Antibodies Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key Biosimilar Monoclonal Antibodies Players
Table 140. Biosimilar Monoclonal Antibodies Customers List
Table 141. Biosimilar Monoclonal Antibodies Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of FiguresFigure 1. Biosimilar Monoclonal Antibodies Product Picture
Figure 2. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2020 & 2026
Figure 3. Infliximab Product Picture
Figure 4. Rituximab Product Picture
Figure 5. Trastuzumab Product Picture
Figure 6. Adalimumab Product Picture
Figure 7. Other Product Picture
Figure 8. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2020 & 2026
Figure 9. Oncology
Figure 10. Autoimmune Disease
Figure 11. Other
Figure 12. Biosimilar Monoclonal Antibodies Report Years Considered
Figure 13. Global Biosimilar Monoclonal Antibodies Market Size 2015-2026 (US$ Million)
Figure 14. Global Biosimilar Monoclonal Antibodies Sales 2015-2026 (K Units)
Figure 15. Global Biosimilar Monoclonal Antibodies Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region (2015-2020)
Figure 17. Global Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2019
Figure 18. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region (2015-2020)
Figure 19. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2019
Figure 20. Global Biosimilar Monoclonal Antibodies Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Biosimilar Monoclonal Antibodies Revenue in 2019
Figure 22. Biosimilar Monoclonal Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type (2015-2020)
Figure 24. Global Biosimilar Monoclonal Antibodies Sales Market Share by Type in 2019
Figure 25. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type (2015-2020)
Figure 26. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Type in 2019
Figure 27. Global Biosimilar Monoclonal Antibodies Market Share by Price Range (2015-2020)
Figure 28. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application (2015-2020)
Figure 29. Global Biosimilar Monoclonal Antibodies Sales Market Share by Application in 2019
Figure 30. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application (2015-2020)
Figure 31. Global Biosimilar Monoclonal Antibodies Revenue Market Share by Application in 2019
Figure 32. North America Biosimilar Monoclonal Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 33. North America Biosimilar Monoclonal Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 35. North America Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 36. U.S. Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 37. U.S. Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 39. Canada Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Biosimilar Monoclonal Antibodies Market Share by Type in 2019
Figure 41. North America Biosimilar Monoclonal Antibodies Market Share by Application in 2019
Figure 42. Europe Biosimilar Monoclonal Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 43. Europe Biosimilar Monoclonal Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Biosimilar Monoclonal Antibodies Sales Market Share by Country in 2019
Figure 45. Europe Biosimilar Monoclonal Antibodies Revenue Market Share by Country in 2019
Figure 46. Germany Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 47. Germany Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 49. France Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 51. U.K. Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 53. Italy Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 55. Russia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Biosimilar Monoclonal Antibodies Market Share by Type in 2019
Figure 57. Europe Biosimilar Monoclonal Antibodies Market Share by Application in 2019
Figure 58. Asia Pacific Biosimilar Monoclonal Antibodies Sales Growth Rate 2015-2020 (K Units)
Figure 59. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Biosimilar Monoclonal Antibodies Sales Market Share by Region in 2019
Figure 61. Asia Pacific Biosimilar Monoclonal Antibodies Revenue Market Share by Region in 2019
Figure 62. China Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 63. China Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 65. Japan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 67. South Korea Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 69. India Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 71. Australia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 73. Taiwan Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 75. Indonesia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 77. Thailand Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 79. Malaysia Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 81. Philippines Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Biosimilar Monoclonal Antibodies Sales Growth Rate (2015-2020) (K Units)
Figure 83. Vietnam Biosimilar Monoclonal Antibodies Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Biosimilar Monoclonal Antibodies Market Share by Type in 2019
Figure 85. Asia Pacific Biosimilar Monoclonal Antibodies Market Share by Application in 2019
Figure 86. Latin America Biosimilar Monoclonal Antibodies